These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 27826183)
1. Supratherapeutic dose evaluation and effect of lesinurad on cardiac repolarization: a thorough QT/QTc study. Shen Z; Gillen M; Tieu K; Nguyen M; Harmon E; Wilson DM; Kerr B; Lee CA Drug Des Devel Ther; 2016; 10():3509-3517. PubMed ID: 27826183 [TBL] [Abstract][Full Text] [Related]
2. Effects of Therapeutic and Supratherapeutic Doses of Siponimod (BAF312) on Cardiac Repolarization in Healthy Subjects. Shakeri-Nejad K; Aslanis V; Veldandi UK; Mooney L; Pezous N; Brendani B; Juan A; Allison M; Perry R; Legangneux E Clin Ther; 2015 Nov; 37(11):2489-2505.e2. PubMed ID: 26519230 [TBL] [Abstract][Full Text] [Related]
3. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials. Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895 [TBL] [Abstract][Full Text] [Related]
4. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study. de Kam PJ; van Kuijk J; Prohn M; Thomsen T; Peeters P Clin Drug Investig; 2010; 30(9):599-611. PubMed ID: 20568829 [TBL] [Abstract][Full Text] [Related]
5. A Randomized Trial to Assess the Effect of Doravirine on the QTc Interval Using a Single Supratherapeutic Dose in Healthy Adult Volunteers. Khalilieh SG; Yee KL; Fan L; Liu R; Heber W; Dunzo E; Triantafyllou I; Hussaini A; Iwamoto M Clin Drug Investig; 2017 Oct; 37(10):975-984. PubMed ID: 28785879 [TBL] [Abstract][Full Text] [Related]
6. Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects. Davis JD; Hackman F; Layton G; Higgins T; Sudworth D; Weissgerber G Br J Clin Pharmacol; 2008 Apr; 65 Suppl 1(Suppl 1):68-75. PubMed ID: 18333868 [TBL] [Abstract][Full Text] [Related]
7. Effects of buprenorphine on QT intervals in healthy subjects: results of 2 randomized positive- and placebo-controlled trials. Harris SC; Morganroth J; Ripa SR; Thorn MD; Colucci S Postgrad Med; 2017 Jan; 129(1):69-80. PubMed ID: 27927048 [TBL] [Abstract][Full Text] [Related]
8. Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers. Kori S; Kellerman DJ; Voloshko P; Haugen G Clin Ther; 2012 Sep; 34(9):1920-8. PubMed ID: 22917853 [TBL] [Abstract][Full Text] [Related]
9. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study. Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264 [TBL] [Abstract][Full Text] [Related]
10. Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women. Stier B; Fossler M; Liu F; Caltabiano S Clin Ther; 2015 Jul; 37(7):1541-54. PubMed ID: 26138866 [TBL] [Abstract][Full Text] [Related]
11. Absence of QTc prolongation with betrixaban: a randomized, double-blind, placebo- and positive-controlled thorough ECG study. Morganroth J; Gretler DD; Hollenbach SJ; Lambing JL; Sinha U Expert Opin Pharmacother; 2013 Jan; 14(1):5-13. PubMed ID: 23216423 [TBL] [Abstract][Full Text] [Related]
12. A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation. Mansbach RS; Ludington E; Rogowski R; Kittrelle JP; Jochelson P Clin Ther; 2011 Jul; 33(7):851-62. PubMed ID: 21722958 [TBL] [Abstract][Full Text] [Related]
13. Dabigatran does not prolong the QT interval with supratherapeutic exposure: a thorough QT study in healthy subjects. Ring A; Rathgen K; Stangier J; Reilly P; Clemens A; Friedman J Clin Drug Investig; 2013 May; 33(5):333-42. PubMed ID: 23519576 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Effect of Selumetinib on Cardiac Repolarization: A Randomized, Placebo- and Positive-controlled Crossover QT/QTc Study in Healthy Subjects. Zhou D; So K; Dymond AW; Vik T; Al-Huniti N; Mariani G; Zorenyi G; Huang Y; Holmes V; Severin P; Rasmussen S; Martin P Clin Ther; 2016 Dec; 38(12):2555-2566. PubMed ID: 27837934 [TBL] [Abstract][Full Text] [Related]
15. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study. de Kam PJ; van Kuijk J; Smeets J; Thomsen T; Peeters P Int J Clin Pharmacol Ther; 2012 Aug; 50(8):595-604. PubMed ID: 22735462 [TBL] [Abstract][Full Text] [Related]
16. Lacosamide cardiac safety: a thorough QT/QTc trial in healthy volunteers. Kropeit D; Johnson M; Cawello W; Rudd GD; Horstmann R Acta Neurol Scand; 2015 Nov; 132(5):346-54. PubMed ID: 25932544 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Eluxadoline Effect on Cardiac Repolarization. Bonifacio L; Hunt TL; McIntyre G; Dove LS; Covington PS Clin Pharmacol Drug Dev; 2018 Sep; 7(7):727-736. PubMed ID: 29659201 [TBL] [Abstract][Full Text] [Related]
18. Loxapine delivered as a thermally generated aerosol does not prolong QTc in a thorough QT/QTc study in healthy subjects. Spyker DA; Voloshko P; Heyman ER; Cassella JV J Clin Pharmacol; 2014 Jun; 54(6):665-74. PubMed ID: 24375070 [TBL] [Abstract][Full Text] [Related]
19. Cardiac repolarization with Gabapentin enacarbil in a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults. Davy M; Upward J; Arumugham T; Twomey C; Chen C; Stier B Clin Ther; 2013 Dec; 35(12):1964-74. PubMed ID: 24290737 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males. Shen Z; Rowlings C; Kerr B; Hingorani V; Manhard K; Quart B; Yeh LT; Storgard C Drug Des Devel Ther; 2015; 9():3423-34. PubMed ID: 26170627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]